Company: BUDZ
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001096906-25-000350
Chunk: 444

Company: WEED, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 444
---
 accompanying consolidated balance sheet at December
31, 2024, has been derived from audited consolidated financial statements and the unaudited condensed consolidated financial statements
as of December 31, 2024 and 2023 ( the “financial statements”), have been prepared in accordance with accounting principles
generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to
Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for
complete financial statements and should be read in conjunction with the audited consolidated financial statements and related footnotes.
It is management’s opinion, however, that all material adjustments (consisting of normal recurring adjustments), have been made
which are necessary for a fair financial statements presentation. The consolidated financial statements include all material adjustments
(consisting of normal recurring accruals) necessary to make the consolidated financial statements not misleading as required by Regulation
S-X, Rule 10-01. Interim result are not necessarily indicative of results for a full year.

Principles of Consolidation

The accompanying consolidated financial statements
include the accounts of the following entities, all of which are under common control and ownership:

    Schedule of entities under common control and ownership

    State of

    Abbreviated
  
    Name of Entity
     
    Incorporation
     
    Relationship (1&3)
     
    Reference
  
    WEED, Inc.
     
    Nevada
     
    Parent
     
    WEED
  
    Sangre AT, LLC (2)
     
    Wyoming
     
    Subsidiary
     
    Sangre
  
    Hempirical Genetics, LLC (3)
     
    Arizona
     
    Subsidiary
     
    Hempirical Generics

(1) Sangre is a wholly-owned subsidiary of WEED, Inc.

(2) Sangre AT, LLC is doing business as Sangre AgroTech.

(3) Hempirical Genetics, LLC is a wholly-owned subsidiary
of WEED, Inc.

    F-8

Note 1 – Nature of Business and Significant
Accounting Policies (continued)

Principles of Consolidation (continued)

The consolidated financial statements herein contain
the operations of the wholly-owned subsidiary listed above. All significant inter-company transactions have been eliminated in the preparation
of these financial statements. The parent company, WEED and subsidiaries will be collectively referred to